pmcMMWR Morb Mortal Wkly RepMMWR Morb Mortal Wkly RepWRMorbidity and Mortality Weekly Report0149-21951545-861XCenters for Disease Control and Prevention366029339815156mm7201a310.15585/mmwr.mm7201a3ErratumErratum: Vol. 71, No. 460612023061202306120237211515https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.Krow-LucalE , MarinM , SheperskyL , BahtaL , LoehrJ , DoolingK . Measles, mumps, rubella vaccine (PRIORIX): recommendations of the Advisory Committee on Immunization Practices—United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71:1465–70. 10.15585/mmwr.mm7146a1

In the report “Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022,” on page 1465, the second sentence of the first footnote should have read, “In addition, measles postexposure prophylaxis is an off-label indicated use for PRIORIX; measles postexposure prophylaxis is an on-label indicated use for M-M-R II.”